Previous studies have identified significant correlations between FGF-21 levels and metabolic syndrome (MetS), as well as related disorders such as diabetes mellitus, the progression of kidney disease in diabetes [5], and coronary artery disease. Here, FGF21 is linked to metabolic syndrome.